Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Certain Chinese herbs, especially Cacumen platycladi, can promote hair regrowth and reduce hair loss-related hormone levels in mice.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Skin aging reflects overall body aging and can indicate internal health conditions.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Sebocytes play a key role in controlling androgen levels in human skin.

Testosterone's muscle-building effects do not require its conversion to DHT.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Finasteride shows promise for female hair loss, but more research needed.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

Consider benefits and risks of new alopecia treatments for safety.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.